Appendix 3Y Maria Rivas
Filed with ASX · · 2 pages · English
Telix Pharmaceuticals Limited on 6ix
Earlier from Telix Pharmaceuticals
- Telix Capital Markets Day Presentation November 2026
- Change of Director's Interest Notice - Marie McDonald
- Notification regarding unquoted securities - TLX
- Cancellation of Appendix 2A
- Notice of General Meeting
Follow Telix Pharmaceuticals into a list and get an email when it puts out news.
Follow Telix Pharmaceuticals